Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Raval ICS is a medical technology company that specializes in the development and manufacturing of advanced respiratory care solutions, particularly for intensive care units (ICUs). The company's primary focus is on the Raval ICS system, an innovative closed-circuit suctioning device designed to maintain lung volume and oxygenation during the removal of secretions from intubated patients. By preventing alveolar collapse and reducing the risk of ventilator-associated pneumonia (VAP), Raval ICS aims to improve patient outcomes in critical care settings. The company's products are utilized globally by healthcare providers to enhance the safety and efficacy of mechanical ventilation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Raval ICS.